The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia

Psychoneuroendocrinology. 1986;11(1):15-37. doi: 10.1016/0306-4530(86)90029-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age Factors
  • Animals
  • Antipsychotic Agents / pharmacology
  • Binding Sites
  • Brain / metabolism
  • Brain Chemistry
  • Central Nervous System / physiology*
  • Corpus Striatum / metabolism
  • Dopamine / physiology*
  • Histocytochemistry
  • Humans
  • Immunochemistry
  • Injections, Intraventricular
  • Limbic System / metabolism
  • Limbic System / physiology
  • Mice
  • Neurotensin / analysis
  • Neurotensin / metabolism
  • Neurotensin / pharmacology
  • Norepinephrine / physiology*
  • Rats
  • Schizophrenia / drug therapy
  • Schizophrenia / etiology*
  • Substantia Nigra / metabolism
  • Synaptic Transmission

Substances

  • Antipsychotic Agents
  • Neurotensin
  • Dopamine
  • Norepinephrine